Literature DB >> 21067268

The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro.

D Wang1, F He, L Zhang, F Zhang, Q Wang, X Qian, X Pan, J Meng, C Peng, A Shen, J Chen.   

Abstract

Until recently, Cip/Kip members were almost solely viewed as nuclear proteins with a principal function of inhibiting cyclin/cyclin dependent kinase (CDK) activity and hence, inhibiting cell cycle progression. P27(Kip1) (hereafter p27) belongs to the Cip/Kip family that binds and inhibits all the cyclin/CDK complexes, thus often referred as a universal CDK inhibitor. However, emerging studies now suggest that Cip/Kip proteins play additional roles outside of the nucleus. Indeed, previous reports have linked p27 to the regulation of actin dynamics and cell migration. In this study, we constructed a model of migration-activated glioma cells by using the migration-stimulating substrate, a kind of ECM, laminin in vitro. Our results present evidence that laminin drives glioma cell migration without altering cell proliferation. Further, actively migrating cells which expressioned high phosphorylation of p27 at Ser10, and induced its cytoplasmic localization. In this process, Jab1 and CRM1 were also involved. Thus phosphorylation of p27 at Ser10 is necessary for both cytoplasmic localization and induction of cell migration. These observations solidified a genetic role of p27 in cell migration and this was independent of cyclin/CDK inhibition. Eventually, we transiently transfected p27S10A into T98G glioma cells, found that overexpression of p27S10A inhibited cell migration but not cell proliferation. These data linked phosphorylation of p27 at Ser10 and cell motility. Therefore, the major phosphorylation site at Ser10 of p27 played a pivotal role in the migration of malignant glioma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21067268

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  9 in total

1.  Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27(KIP1).

Authors:  Dan Ma; Dan Guo; Wei Li; Hongwen Zhao
Journal:  Tumour Biol       Date:  2015-04-09

2.  Assembly, activation, and substrate specificity of cyclin D1/Cdk2 complexes.

Authors:  Stephan C Jahn; Mary E Law; Patrick E Corsino; Thomas C Rowe; Bradley J Davis; Brian K Law
Journal:  Biochemistry       Date:  2013-05-09       Impact factor: 3.162

3.  Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility.

Authors:  Giovanna Maria Pierantoni; Francesco Esposito; Mara Tornincasa; Cinzia Rinaldo; Giuseppe Viglietto; Silvia Soddu; Alfredo Fusco
Journal:  J Biol Chem       Date:  2011-06-29       Impact factor: 5.157

4.  p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.

Authors:  Yiting Li; Manjula Nakka; Aaron J Kelly; Ching C Lau; Mark Krailo; Donald A Barkauskas; John M Hicks; Tsz-Kwong Man
Journal:  Cancer Res       Date:  2016-04-19       Impact factor: 12.701

5.  CRM1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.

Authors:  Hiromi Inoue; Michael Kauffman; Sharon Shacham; Yosef Landesman; Joy Yang; Christopher P Evans; Robert H Weiss
Journal:  J Urol       Date:  2012-10-16       Impact factor: 7.450

Review 6.  Inhibiting cancer cell hallmark features through nuclear export inhibition.

Authors:  Qingxiang Sun; Xueqin Chen; Qiao Zhou; Ezra Burstein; Shengyong Yang; Da Jia
Journal:  Signal Transduct Target Ther       Date:  2016-07-01

7.  Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27.

Authors:  Heidi Högel; Petra Miikkulainen; Lucia Bino; Panu M Jaakkola
Journal:  Mol Cancer       Date:  2015-07-30       Impact factor: 27.401

8.  Jab1 regulates Schwann cell proliferation and axonal sorting through p27.

Authors:  Emanuela Porrello; Cristina Rivellini; Giorgia Dina; Daniela Triolo; Ubaldo Del Carro; Daniela Ungaro; Martina Panattoni; Maria Laura Feltri; Lawrence Wrabetz; Ruggero Pardi; Angelo Quattrini; Stefano Carlo Previtali
Journal:  J Exp Med       Date:  2013-12-16       Impact factor: 14.307

9.  XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa).

Authors:  Giovanni Luca Gravina; Monica Tortoreto; Andrea Mancini; Alessandro Addis; Ernesto Di Cesare; Andrea Lenzi; Yosef Landesman; Dilara McCauley; Michael Kauffman; Sharon Shacham; Nadia Zaffaroni; Claudio Festuccia
Journal:  J Hematol Oncol       Date:  2014-10-05       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.